Prenatal Antidepressant Exposures and Autism Spectrum Disorder or Traits: A Retrospective, Multi-Cohort Study
- PMID: 36417100
- PMCID: PMC10150657
- DOI: 10.1007/s10802-022-01000-5
Prenatal Antidepressant Exposures and Autism Spectrum Disorder or Traits: A Retrospective, Multi-Cohort Study
Abstract
Prenatal antidepressant exposure has been associated with increased risk for neurodevelopmental disorders in childhood, including autism spectrum disorder (ASD). The current study utilized multi-cohort data from the Environmental influences on Child Health Outcomes (ECHO) program (N = 3129) to test for this association, and determine whether the association remained after adjusting for maternal prenatal depression and other potential confounders. Antidepressants and a subset of selective serotonin reuptake inhibitors (SSRIs) were examined in relation to binary (e.g., diagnostic) and continuous measures of ASD and ASD related traits (e.g., social difficulties, behavior problems) in children 1.5 to 12 years of age. Child sex was tested as an effect modifier. While prenatal antidepressant exposure was associated with ASD related traits in univariate analyses, these associations were statistically non-significant in models that adjusted for prenatal maternal depression and other maternal and child characteristics. Sex assigned at birth was not an effect modifier for the prenatal antidepressant and child ASD relationship. Overall, we found no association between prenatal antidepressant exposures and ASD diagnoses or traits. Discontinuation of antidepressants in pregnancy does not appear to be warranted on the basis of increased risk for offspring ASD.
Keywords: Antidepressants; Autism spectrum disorder; Neurodevelopment; Prenatal.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Conflicts of Interest
None noted
References
-
- Achenbach T (2001). Child Behavior Checklist for Ages 6–18. ASEBA, University of Vermont.
-
- Achenbach TM (2014). DSM-Oriented guide for the Achenbach System of Empirically Based Assessment (ASEBA). Center for Children, Youth and Families, The University of Vermont.
-
- Achenbach T, & Rescorla L (2000). Child Behavior Checklist for Ages 1 1/2–5 ASEBA, University of Vermont.
-
- Ames JL, Ladd-Acosta C, Fallin MD, Qian Y, Schieve LA, DiGuiseppi C, Lee LC, Kasten EP, Zhou G, Pinto-Martin J, Howerton EM, Eaton CL, & Croen LA (2021). Maternal psychiatric conditions, treatment with selective serotonin reuptake inhibitors, and neurodevelopmental disorders. Biological Psychiatry, 90(4), 253–262. - PMC - PubMed
-
- Andrade C (2017a). Antidepressant exposure during pregnancy and risk of autism in the offspring, 1: Meta-review of meta-analyses. The Journal of Clinical Psychiatry, 78(8), 905. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UH3 OD023249/OD/NIH HHS/United States
- U2C OD023375/OD/NIH HHS/United States
- UH3 OD023285/OD/NIH HHS/United States
- UG3 OD023320/OD/NIH HHS/United States
- UH3 OD023318/OD/NIH HHS/United States
- UH3 OD023271/OD/NIH HHS/United States
- UH3 OD023282/OD/NIH HHS/United States
- U24 OD023319/OD/NIH HHS/United States
- UH3 OD023305/OD/NIH HHS/United States
- UH3 OD023272/OD/NIH HHS/United States
- UG3 OD023282/OD/NIH HHS/United States
- UH3 OD023347/OD/NIH HHS/United States
- UH3 OD023279/OD/NIH HHS/United States
- UH3 OD023342/OD/NIH HHS/United States
- U24 OD023382/OD/NIH HHS/United States
- UH3 OD023313/OD/NIH HHS/United States
- UL1 TR002538/TR/NCATS NIH HHS/United States
- UH3 OD023286/OD/NIH HHS/United States
- R24 ES029490/ES/NIEHS NIH HHS/United States
- UH3 OD023244/OD/NIH HHS/United States
- UH3 OD023320/OD/NIH HHS/United States
- UH3 OD023349/OD/NIH HHS/United States
- UH3 OD023365/OD/NIH HHS/United States
- UG3 OD023285/OD/NIH HHS/United States
- UH3 OD023337/OD/NIH HHS/United States
- UG3 OD023318/OD/NIH HHS/United States
- UG3 OD023249/OD/NIH HHS/United States
- UH3 OD023328/OD/NIH HHS/United States